Haemonetics Corporation (HAE)
NYSE: HAE · Surgical & Medical Instruments & Apparatus · Boston, MA · filing with the SEC since 1996
Grade5.7
◀ Past 6.8● Present 6.5▶ Future 3.4
Who owns Haemonetics Corporation
As filed with the SECHolders of 5% or more
2
Vanguard Portfolio Management holds 5.59% of Common Stock, as its SCHEDULE 13G filed Apr 29, 2026 says.
Directors and officers
15
report now, of 35 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Vanguard Portfolio Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
AQR Capital Management, LLC
SCHEDULE 13G/A · filed Aug 12, 2026 · Common stock, $0.01 par value per share · reported falling below 5%, from 6.76% in Feb 13, 2026
Wellington Management Group LLP
SCHEDULE 13G/A · filed Aug 12, 2025 · Common Stock · reported falling below 5%, from 5.4% in May 12, 2025
T. Rowe Price Investment Management, Inc.
SCHEDULE 13G/A · filed May 14, 2025 · COMMON STOCK · reported falling below 5%
Capital Research Global Investors
SCHEDULE 13G/A · filed Apr 4, 2025 · Common Stock · reported falling below 5%
North Peak Capital Management, LLC
SCHEDULE 13G/A · filed May 13, 2026 · Common stock, $.01 par value per share · reported falling below 5%, from 5.1% in Mar 3, 2026
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What HAE reports owning in othersstakes of 5% or more, and other ties
36 subsidiaries in 20 countries, from the list filed with the 10-K filed May 20, 2026.
Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Nov 3, 2025 to Nov 3, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Nov 3, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 35 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Kroll Mark W | director | 0 | $0 | 0 | 1 | $100,000 |